Clinical Effectiveness of the Queen Square Intensive Comprehensive Aphasia Service for Patients With Poststroke Aphasia.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 11 6 2021
medline: 8 1 2022
entrez: 10 6 2021
Statut: ppublish

Résumé

Poststroke aphasia has a major impact on peoples’ quality of life. Speech and language therapy interventions work, especially in high doses, but these doses are rarely achieved outside of research studies. Intensive Comprehensive Aphasia Programs (ICAPs) are an option to deliver high doses of therapy to people with aphasia over a short period of time. Forty-six people with aphasia in the chronic stage poststroke completed the ICAP over a 3-week period, attending for 15 days and averaging 6 hours of therapy per day. Outcome measures included the Comprehensive Aphasia Test, an impairment-based test of the 4 main domains of language (speaking, writing, auditory comprehension, and reading) which was measured at 3 time points (baseline, immediately posttreatment at 3 weeks and follow-up at 12-week post-ICAP); and, the Communicative Effectiveness Index, a carer-reported measure of functional communication skills collected at baseline and 12 weeks. A 2-way repeated measures multivariate ANOVA was conducted. We found a significant domain-by-time interaction, F=12.7, P<0.0005, indicating that the ICAP improved people with aphasia’s language scores across all 4 domains, with the largest gains in speaking (Cohen’s d=1.3). All gains were maintained or significantly improved further at 12-week post-ICAP. Importantly, patients’ functional communication, as indexed by changes on the Communicative Effectiveness Index, also significantly improved at 12-week post-ICAP, t=5.4, P<0.0005, also with a large effect size (Cohen’s d=0.9). People with aphasia who participated in the Queen Square ICAP made large and clinically meaningful gains on both impairment-based and functional measures of language. Gains were sustained and in some cases improved further over the subsequent 12 weeks.

Sections du résumé

Background and Purpose
Poststroke aphasia has a major impact on peoples’ quality of life. Speech and language therapy interventions work, especially in high doses, but these doses are rarely achieved outside of research studies. Intensive Comprehensive Aphasia Programs (ICAPs) are an option to deliver high doses of therapy to people with aphasia over a short period of time.
Methods
Forty-six people with aphasia in the chronic stage poststroke completed the ICAP over a 3-week period, attending for 15 days and averaging 6 hours of therapy per day. Outcome measures included the Comprehensive Aphasia Test, an impairment-based test of the 4 main domains of language (speaking, writing, auditory comprehension, and reading) which was measured at 3 time points (baseline, immediately posttreatment at 3 weeks and follow-up at 12-week post-ICAP); and, the Communicative Effectiveness Index, a carer-reported measure of functional communication skills collected at baseline and 12 weeks.
Results
A 2-way repeated measures multivariate ANOVA was conducted. We found a significant domain-by-time interaction, F=12.7, P<0.0005, indicating that the ICAP improved people with aphasia’s language scores across all 4 domains, with the largest gains in speaking (Cohen’s d=1.3). All gains were maintained or significantly improved further at 12-week post-ICAP. Importantly, patients’ functional communication, as indexed by changes on the Communicative Effectiveness Index, also significantly improved at 12-week post-ICAP, t=5.4, P<0.0005, also with a large effect size (Cohen’s d=0.9).
Conclusions
People with aphasia who participated in the Queen Square ICAP made large and clinically meaningful gains on both impairment-based and functional measures of language. Gains were sustained and in some cases improved further over the subsequent 12 weeks.

Identifiants

pubmed: 34107735
doi: 10.1161/STROKEAHA.120.033837
pmc: PMC8478085
mid: EMS126116
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e594-e598

Subventions

Organisme : Wellcome Trust
ID : 106161
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 106161/Z/14/Z
Pays : United Kingdom

Références

Top Stroke Rehabil. 2013 Sep-Oct;20(5):379-87
pubmed: 24091280
Am J Speech Lang Pathol. 2014 May;23(2):S330-42
pubmed: 24687159
J Speech Hear Disord. 1989 Feb;54(1):113-24
pubmed: 2464719
Cochrane Database Syst Rev. 2016 Jun 01;(6):CD000425
pubmed: 27245310
J Neurol Neurosurg Psychiatry. 2020 Nov 5;:
pubmed: 33154182
Am J Speech Lang Pathol. 2015 Nov;24(4):S854-63
pubmed: 26140692
Disabil Rehabil. 1996 Nov;18(11):567-84
pubmed: 9233854
J Neurol Neurosurg Psychiatry. 2019 May;90(5):498-506
pubmed: 30770457
Top Stroke Rehabil. 2017 Mar;24(2):82-90
pubmed: 27456043
Med Care. 2010 Apr;48(4):380-7
pubmed: 20220536
Stroke. 2003 Apr;34(4):987-93
pubmed: 12649521

Auteurs

Alexander P Leff (AP)

UCL Queen Square Institute of Neurology (A.P.L., S.N.), University College London, United Kingdom.
University College London Hospitals NHS Trust, United Kingdom (A.P.L., B.G., A.S., A.P., J.D., N.K., C.J.).

Sarah Nightingale (S)

UCL Queen Square Institute of Neurology (A.P.L., S.N.), University College London, United Kingdom.

Beth Gooding (B)

University College London Hospitals NHS Trust, United Kingdom (A.P.L., B.G., A.S., A.P., J.D., N.K., C.J.).

Jean Rutter (J)

Linguistic Resolutions, United Kingdom (J.R., C.F.-D.).

Nicola Craven (N)

Royal London Hospital, Barts Health NHS Trust, United Kingdom (N.C.).

Makena Peart (M)

City, University of London, United Kingdom (M.P.).

Alice Dunstan (A)

Homerton University Hospital NHS Foundation Trust, United Kingdom (A.D.).

Amy Sherman (A)

University College London Hospitals NHS Trust, United Kingdom (A.P.L., B.G., A.S., A.P., J.D., N.K., C.J.).

Andrew Paget (A)

University College London Hospitals NHS Trust, United Kingdom (A.P.L., B.G., A.S., A.P., J.D., N.K., C.J.).

Morvwen Duncan (M)

Great Ormond Street Hospital for Children NHS Foundation Trust, United Kingdom (M.D.).

Jonathan Davidson (J)

University College London Hospitals NHS Trust, United Kingdom (A.P.L., B.G., A.S., A.P., J.D., N.K., C.J.).

Naveen Kumar (N)

University College London Hospitals NHS Trust, United Kingdom (A.P.L., B.G., A.S., A.P., J.D., N.K., C.J.).

Claire Farrington-Douglas (C)

Linguistic Resolutions, United Kingdom (J.R., C.F.-D.).

Camille Julien (C)

University College London Hospitals NHS Trust, United Kingdom (A.P.L., B.G., A.S., A.P., J.D., N.K., C.J.).

Jennifer T Crinion (JT)

Institute of Cognitive Neuroscience (J.T.C.), University College London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH